Drug-screening and genomic analyses of HER2-positive breast cancer cell lines reveal predictors for treatment response

Overview of attention for article published in Breast cancer targets and therapy, March 2017

Altmetric Badge

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 28 Dimensions

Readers on

mendeley: 89 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 28 publications that cite this research output.

28

The most recent citing publications are shown below. View all 28 publications that cite this research output on Dimensions.

Molecular, Cellular, and Technical Aspects of Breast Cancer Cell Lines as a Foundational Tool in Cancer Research

Article in Life (December 2023)

Macrolide and Ketolide Antibiotics Inhibit the Cytotoxic Effect of Trastuzumab Emtansine in HER2-Positive Breast Cancer Cells: Implication of a Potential Drug–ADC Interaction in Cancer Chemotherapy

Article in Molecular Pharmaceutics (November 2023)

High-throughput screen in vitro identifies dasatinib as a candidate for combinatorial treatment with HER2-targeting drugs in breast cancer

Article in PLOS ONE (January 2023)